Polymyxin-B endotoxin removal device: making the point on mechanisms of action, clinical effectiveness and possible

Franco Ruberto1, S Ianni, C Babetto

  • 1Department of Anesthesiology and Intensive Care Medicine, Sapienza Universita di Roma, Policlinico Umberto I, viale del Policlinico 155, 00161 Rome, Italy. rube2005@libero.it

Insights

Polymyxin B (PMX) cartridges offer an effective apheresis method for removing endotoxins, improving patient outcomes in sepsis. Further research is needed to broaden its clinical applications.

Area of Science:

  • Medical Technology
  • Nephrology
  • Critical Care Medicine

Background:

  • Endotoxins from Gram-negative bacteria are a major cause of sepsis.
  • Intravenous Polymyxin B is toxic, limiting its use.
  • Polymyxin B cartridges (PMX) were developed to safely remove endotoxins via apheresis.

Purpose of the Study:

  • To review current information on apheresis procedures using Polymyxin B cartridges for endotoxin removal.
  • To summarize the mechanisms, clinical use, and effectiveness of PMX in sepsis treatment.
  • To highlight the need for further research to expand PMX applications.

Main Methods:

  • Review of over one hundred published studies on the clinical use of PMX cartridges.
  • Analysis of data on clinical condition, hemodynamic parameters, respiratory function (PaO2/FiO2 ratio), and severity scores (APACHE, SOFA).
  • Evaluation of patient outcomes, including 28-day survival, across various sepsis types.

Main Results:

  • PMX apheresis demonstrates a positive impact on clinical condition and patient outcomes.
  • Studies show improvements in hemodynamic stability, PaO2/FiO2 ratio, and reduced severity scores.
  • Benefits are observed in diverse sepsis cases, including those in transplanted patients.

Conclusions:

  • Polymyxin B cartridges are a promising tool for treating Gram-negative and endotoxin sepsis.
  • PMX offers clinical and outcome improvements with a favorable cost-effectiveness ratio.
  • Wider, structured clinical studies are required to solidify PMX use and expand its indications.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...